UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

_________________

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number  000-55557

 

CEN BIOTECH, INC.

 

(Exact name of registrant as specified in its charter)

 

300-3295 Quality Way

Windsor, Ontario

Canada

N8T 3R9

(519) 419-4958

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, No Par Value per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

☐
     
 

Rule 12g-4(a)(2)

☒

  
       
 

Rule 12h-3(b)(1)(i)

☐

  
       
 

Rule 12h-3(b)(1)(ii)

☐

  
       
 

Rule 15d-6

☐

  

 

Approximate number of holders of record as of the certification or notice date:  380

 

Pursuant to the requirements of the Securities Exchange Act of 1934 CEN Biotech, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Date:  

April 12, 2023

  

By:

/s/ Brian S. Payne
       

Brian S. Payne
Chief Executive Officer

 

 
Grafico Azioni CEN Biotech (CE) (USOTC:CENBF)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di CEN Biotech (CE)
Grafico Azioni CEN Biotech (CE) (USOTC:CENBF)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di CEN Biotech (CE)